The PI3K-AKT-mTOR pathway, crucial for microglial response to amyloid-β (Aβ) deposition, peptide is considered a critical neurotoxic agent in AD pathology and is activated by TREM2 [67] (Table 1). This evidence concerns the gene TREM2 and Alzheimer disease.